THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 114 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $201 | -32.6% | 23,269 | -19.3% | 0.00% | – |
| Q2 2023 | $298 | -24.9% | 28,823 | -21.3% | 0.00% | – |
| Q1 2023 | $397 | +49.8% | 36,602 | +54.9% | 0.00% | – |
| Q4 2022 | $265 | -99.8% | 23,623 | +111.0% | 0.00% | – |
| Q3 2022 | $114,000 | -40.0% | 11,198 | -46.6% | 0.00% | – |
| Q2 2022 | $190,000 | -30.7% | 20,967 | -26.8% | 0.00% | – |
| Q1 2022 | $274,000 | -86.9% | 28,624 | -84.8% | 0.00% | – |
| Q4 2021 | $2,088,000 | +380.0% | 188,818 | +221.2% | 0.00% | – |
| Q3 2021 | $435,000 | +335.0% | 58,790 | +756.0% | 0.00% | – |
| Q2 2021 | $100,000 | -90.4% | 6,868 | -86.6% | 0.00% | -100.0% |
| Q1 2021 | $1,047,000 | +125.6% | 51,320 | +96.6% | 0.00% | – |
| Q4 2020 | $464,000 | -27.2% | 26,104 | -39.5% | 0.00% | – |
| Q3 2020 | $637,000 | -57.4% | 43,120 | -39.5% | 0.00% | -100.0% |
| Q2 2020 | $1,495,000 | +48.8% | 71,244 | +63.7% | 0.00% | 0.0% |
| Q1 2020 | $1,005,000 | -29.0% | 43,523 | -20.4% | 0.00% | 0.0% |
| Q4 2019 | $1,416,000 | +61.1% | 54,708 | +21.4% | 0.00% | 0.0% |
| Q3 2019 | $879,000 | -51.2% | 45,080 | -59.1% | 0.00% | 0.0% |
| Q2 2019 | $1,800,000 | +80.0% | 110,239 | +150.0% | 0.00% | 0.0% |
| Q1 2019 | $1,000,000 | +107.9% | 44,093 | +135.1% | 0.00% | – |
| Q4 2018 | $481,000 | -53.3% | 18,752 | -40.4% | 0.00% | -100.0% |
| Q3 2018 | $1,029,000 | -53.8% | 31,486 | -67.9% | 0.00% | -50.0% |
| Q2 2018 | $2,227,000 | -14.0% | 98,139 | -8.1% | 0.00% | 0.0% |
| Q1 2018 | $2,590,000 | +944.4% | 106,825 | +1101.4% | 0.00% | – |
| Q4 2017 | $248,000 | +213.9% | 8,892 | +281.6% | 0.00% | – |
| Q3 2017 | $79,000 | +11.3% | 2,330 | +31.9% | 0.00% | – |
| Q2 2017 | $71,000 | -88.3% | 1,767 | -89.3% | 0.00% | -100.0% |
| Q1 2017 | $607,000 | +427.8% | 16,475 | +355.4% | 0.00% | – |
| Q4 2016 | $115,000 | +62.0% | 3,618 | +87.9% | 0.00% | – |
| Q3 2016 | $71,000 | -76.7% | 1,926 | -85.7% | 0.00% | – |
| Q2 2016 | $305,000 | +4257.1% | 13,489 | +3421.9% | 0.00% | – |
| Q1 2016 | $7,000 | -93.8% | 383 | -94.6% | 0.00% | – |
| Q4 2015 | $113,000 | +25.6% | 7,050 | -22.2% | 0.00% | – |
| Q3 2015 | $90,000 | +1185.7% | 9,057 | +1486.2% | 0.00% | – |
| Q2 2015 | $7,000 | -63.2% | 571 | -49.8% | 0.00% | – |
| Q1 2015 | $19,000 | -75.0% | 1,138 | -78.5% | 0.00% | – |
| Q4 2014 | $76,000 | -30.3% | 5,304 | +13.0% | 0.00% | – |
| Q3 2014 | $109,000 | -61.8% | 4,692 | -48.7% | 0.00% | – |
| Q2 2014 | $285,000 | – | 9,145 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |